Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-6.24%
↑ 75% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-25.08%
Historical baseline
PeriodValue
2024-6.24%
202339.01%
2022-24.48%
2021-177.01%
2020-6.36%
2019-0.50%
20180.00%